Bibliotecas PUC-SP - Busca Integrada

In-Fusion™ assembly: seamless engineering of multidomain fusion proteins, modular vectors, and mutations

著者: Baogong Zhu, Guifang Cai, Emily O. Hall, Gordon J. Freeman
出版年 BioTechniques (2007-09-01)

Expression of lectin-like transcript-1 in human tissues [version 1; referees: 1 approved, 2 approved with reservations]

著者: Alba Llibre, Lucy Garner, Amy Partridge, Gordon J. Freeman, Paul Klenerman, Chris B. Willberg
出版年 F1000Research (2016-12-01)

Defective TFH Cell Function and Increased TFR Cells Contribute to Defective Antibody Production in Aging

著者: Peter T. Sage, Catherine L. Tan, Gordon J. Freeman, Marcia Haigis, Arlene H. Sharpe
出版年 Cell Reports (2015-07-01)

PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads.

著者: Edward Seung, Timothy E Dudek, Todd M Allen, Gordon J Freeman, Andrew D Luster, Andrew M Tager
出版年 PLoS ONE (2013-01-01)

PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity

著者: Jing Liu, Xia Bu, Chen Chu, Xiaoming Dai, John M. Asara, Piotr Sicinski, Gordon J. Freeman, Wenyi Wei
出版年 Nature Communications (2023-05-01)

mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion

著者: Heng-Jia Liu, Heng Du, Damir Khabibullin, Mahsa Zarei, Kevin Wei, Gordon J. Freeman, David J. Kwiatkowski, Elizabeth P. Henske
出版年 Nature Communications (2023-03-01)

An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy

著者: Sarah C. Cowles, Allison Sheen, Luciano Santollani, Emi A. Lutz, Brianna M. Lax, Joseph R. Palmeri, Gordon J. Freeman, K. Dane Wittrup
出版年 mAbs (2022-12-01)

Inclusion of CD80 in HSV targets the recombinant virus to PD-L1 on DCs and allows productive infection and robust immune responses.

著者: Kevin R Mott, Sariah J Allen, Mandana Zandian, Omid Akbari, Pedram Hamrah, Hadi Maazi, Steven L Wechsler, Arlene H Sharpe, Gordon J Freeman, Homayon Ghiasi
出版年 PLoS ONE (2014-01-01)

CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival.

著者: Francesca D'Addio, Takuya Ueno, Michael Clarkson, Baogong Zhu, Andrea Vergani, Gordon J Freeman, Mohamed H Sayegh, Mohammed Javeed I Ansari, Paolo Fiorina, Antje Habicht
出版年 PLoS ONE (2013-01-01)

The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy

著者: Apoorvi Chaudhri, Apoorvi Chaudhri, Apoorvi Chaudhri, Apoorvi Chaudhri, Xia Bu, Xia Bu, Yunfei Wang, Michael Gomez, Michael Gomez, James A. Torchia, James A. Torchia, Ping Hua, Ping Hua, Shao-Hsi Hung, Shao-Hsi Hung, Michael A. Davies, Gregory A. Lizee, Ulrich von Andrian, Ulrich von Andrian, Ulrich von Andrian, Patrick Hwu, Gordon J. Freeman, Gordon J. Freeman
出版年 Frontiers in Immunology (2023-09-01)

The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018

著者: Paolo A. Ascierto, Lisa H. Butterfield, Sandra Demaria, Robert L. Ferris, Gordon J. Freeman, Roger S. Lo, Alberto Mantovani, Paul Nathan, Omid Hamid, Katerina Politi, Igor Puzanov
出版年 Journal for ImmunoTherapy of Cancer (2019-08-01)

Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.

著者: Nobuhiro Nakamoto, Hyosun Cho, Abraham Shaked, Kim Olthoff, Mary E Valiga, Mary Kaminski, Emma Gostick, David A Price, Gordon J Freeman, E John Wherry, Kyong-Mi Chang
出版年 PLoS Pathogens (2009-02-01)

Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation

著者: Bettina P. Iliopoulou, Katie Hsu, Magdiel Pérez-Cruz, Sai-Wen Tang, Wendy W. Pang, Tom Erkers, Neeraja Kambham, Gordon J. Freeman, Rosemarie H. Dekruyff, Everett H. Meyer
出版年 Blood Advances (2019-11-01)

mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection

著者: Satomi Ando, Charles M. Perkins, Yamato Sajiki, Chase Chastain, Rajesh M. Valanparambil, Andreas Wieland, William H. Hudson, Masao Hashimoto, Suresh S. Ramalingam, Gordon J. Freeman, Rafi Ahmed, Koichi Araki
出版年 The Journal of Clinical Investigation (2023-01-01)

Regulation of HHLA2 expression in kidney cancer and myeloid cells

著者: Tomonari Shigemura, Nahuel Perrot, Zimo Huang, Rupal S. Bhatt, Aseman Bagheri Sheshdeh, Nourhan El Ahmar, Fatme Ghandour, Sabina Signoretti, David F. McDermott, Gordon J. Freeman, Kathleen M. Mahoney
出版年 BMC Cancer (2023-10-01)

Soluble PD-L1 as an early marker of progressive disease on nivolumab

著者: David F McDermott, Gordon J Freeman, Toni K Choueiri, Petra Ross-MacDonald, F Stephen Hodi, Megan Wind-Rotolo, Long Yuan, Kathleen M Mahoney, Linan Song, Eliseo Veras
出版年 Journal for ImmunoTherapy of Cancer (2022-02-01)

TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine.

著者: Stephanie Jemielity, Jinyize J Wang, Ying Kai Chan, Asim A Ahmed, Wenhui Li, Sheena Monahan, Xia Bu, Michael Farzan, Gordon J Freeman, Dale T Umetsu, Rosemarie H Dekruyff, Hyeryun Choe
出版年 PLoS Pathogens (2013-03-01)

T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity

著者: Daniela Schmid, Chun Gwon Park, Christina A. Hartl, Nikita Subedi, Adam N. Cartwright, Regina Bou Puerto, Yiran Zheng, James Maiarana, Gordon J. Freeman, Kai W. Wucherpfennig, Darrell J. Irvine, Michael S. Goldberg
出版年 Nature Communications (2017-11-01)

Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function

著者: Elsa Brunet-Ratnasingham, Antigoni Morou, Mathieu Dubé, Julia Niessl, Amy E. Baxter, Olivier Tastet, Nathalie Brassard, Gloria Ortega-Delgado, Roxanne Charlebois, Gordon J. Freeman, Cécile Tremblay, Jean-Pierre Routy, Daniel E. Kaufmann
出版年 EBioMedicine (2022-10-01)

Immunoregulatory effects of RGMb in gut inflammation

著者: Magdiel Pérez-Cruz, Bettina P. Iliopoulou, Katie Hsu, Hsin-Hsu Wu, Tom Erkers, Kavya Swaminathan, Sai-Wen Tang, Cameron S. Bader, Neeraja Kambham, Bryan Xie, Rosemarie H. Dekruyff, Gordon J. Freeman, Everett Meyer
出版年 Frontiers in Immunology (2022-11-01)